Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.7K
Tumor Immunotherapy01:27

Tumor Immunotherapy

575
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
575

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Restaurant Impacts on Outdoor Air Quality: Elevated Organic Aerosol Mass from Restaurant Cooking with Neighborhood-Scale Plume Extents.

Environmental science & technology·2018
Same author

Shifts in functional trait-species abundance relationships over secondary subalpine meadow succession in the Qinghai-Tibetan Plateau.

Oecologia·2018
Same author

<i>Zishenpingchan</i> granules for the treatment of Parkinson's disease: a randomized, double-blind, placebo-controlled clinical trial.

Neural regeneration research·2018
Same author

Tanshinone IIA activates autophagy to reduce liver ischemia-reperfusion injury by MEK/ERK/mTOR pathway.

Die Pharmazie·2018
Same author

[Identification and Characterization of a Hypothermic Alkaliphilic Aerobic Denitrifying Bacterium <i>Pseudomonas monteilii</i> Strain H97].

Huan jing ke xue= Huanjing kexue·2018
Same author

Effect of Zishenpingchan granule prepared from Chinese medicinal substances on the c-Jun N-terminal protein kinase pathway in mice with Parkinson's disease induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.

Journal of traditional Chinese medicine = Chung i tsa chih ying wen pan·2018

Related Experiment Video

Updated: Jul 27, 2025

Targeted Plasma Membrane Delivery of a Hydrophobic Cargo Encapsulated in a Liquid Crystal Nanoparticle Carrier
10:16

Targeted Plasma Membrane Delivery of a Hydrophobic Cargo Encapsulated in a Liquid Crystal Nanoparticle Carrier

Published on: February 8, 2017

7.6K

Hydroxyapatite-based carriers for tumor targeting therapy.

Gongming Qian1,2, Lingya Xiong1, Qing Ye1,2

  • 1College of Resource and Environmental Engineering, Wuhan University of Science & Technology Wuhan 430081 China qiangongming@wust.edu.cn.

RSC Advances
|June 5, 2023
PubMed
Summary
This summary is machine-generated.

Hydroxyapatite (HAP) shows promise as a biocompatible drug carrier for targeted tumor treatment. HAP-based carriers enhance drug loading and cellular uptake, improving therapeutic efficacy.

More Related Videos

Encapsulation of Cancer Therapeutic Agent Dacarbazine Using Nanostructured Lipid Carrier
07:53

Encapsulation of Cancer Therapeutic Agent Dacarbazine Using Nanostructured Lipid Carrier

Published on: April 26, 2016

11.2K
Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?
14:20

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?

Published on: June 13, 2014

16.8K

Related Experiment Videos

Last Updated: Jul 27, 2025

Targeted Plasma Membrane Delivery of a Hydrophobic Cargo Encapsulated in a Liquid Crystal Nanoparticle Carrier
10:16

Targeted Plasma Membrane Delivery of a Hydrophobic Cargo Encapsulated in a Liquid Crystal Nanoparticle Carrier

Published on: February 8, 2017

7.6K
Encapsulation of Cancer Therapeutic Agent Dacarbazine Using Nanostructured Lipid Carrier
07:53

Encapsulation of Cancer Therapeutic Agent Dacarbazine Using Nanostructured Lipid Carrier

Published on: April 26, 2016

11.2K
Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?
14:20

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?

Published on: June 13, 2014

16.8K

Area of Science:

  • Biomaterials Science
  • Nanotechnology
  • Oncology

Background:

  • Targeted drug delivery is crucial for overcoming limitations of conventional chemotherapy in cancer treatment.
  • Hydroxyapatite (HAP), a primary component of bone, offers excellent biocompatibility, non-toxicity, and biodegradability, making it a suitable candidate for drug delivery systems.

Purpose of the Study:

  • This review explores the advancements and potential of hydroxyapatite (HAP) as a carrier for targeted drug delivery in cancer therapy.
  • To highlight HAP-based carriers' ability to improve drug loading efficiency and treatment response.

Main Methods:

  • HAP-based carriers are synthesized through doping, modification, and combination strategies.
  • Loading of therapeutic agents onto HAP carriers is achieved via adsorption or in situ loading.

Main Results:

  • HAP-based carriers demonstrate enhanced drug loading capacity and improved sensitivity to microenvironmental stimuli.
  • These carriers facilitate targeted drug delivery through in vivo microenvironment guidance and in vitro response stimulation.
  • Improved cellular uptake rates of drugs are observed with HAP-based carriers, leading to enhanced treatment outcomes.

Conclusions:

  • Hydroxyapatite (HAP) presents a promising platform for developing advanced drug delivery systems for targeted cancer therapy.
  • HAP-based carriers offer significant advantages in drug loading, targeted delivery, and cellular uptake, paving the way for more effective tumor treatments.